by Editorial | Business Day | 22 January 2026 | Jan 22, 2026 | Archive, January 2026
NHI truce talks could end court battles and shift focus to workable reforms for universal health coverage.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Sinesipho Schrieber | Business Day | 22 January 2026 | Jan 22, 2026 | Archive, January 2026
Afrox Unpaid Invoices spark a R360m lawsuit, highlighting growing hospital debt, late payments, and risks to essential medical gas supplies.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Tamar Kahn | Business Day | 20 January 2026 | Jan 21, 2026 | Archive, January 2026
The NHI Court Challenge crisis deepens as key litigants reject Enoch Godongwana’s settlement push, citing flawed consultation.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Marcus Low | Spotlight | 19 January 2026 | Jan 21, 2026 | Archive, January 2026
Spotlight’s 2026 Healthcare Watchlist highlights nine health topics, from a new HIV prevention jab to NHI court battles and aid shocks.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Abram Mashego | City Press | 18 January 2026 | Jan 21, 2026 | Archive, January 2026
Sizwe Hosmed's regulatory allegations highlight claims of corruption, sabotage and racial bias in South Africa’s medical scheme industry.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Tamar Kahn | Business Day | 19 January 2026 | Jan 19, 2026 | Archive, January 2026
Aspen Pharmacare is lining up a generic semaglutide launch in Canada, promising big discounts, and widening GLP-1 access.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions